DEVICE USES ENGINEERED PROTEIN TO TREAT BACK DISORDER

Article

9 JULY - FDA has approved the first device that uses a genetically engineered human protein for use in the lower region of the spine to treat degenerative disc disease, a major cause of back pain for many adults.

DEVICE USES ENGINEERED PROTEIN TO TREAT BACKDISORDER -- FDA has approved the first device that uses agenetically engineered human protein for use in the lower regionof the spine to treat degenerative disc disease, a major cause ofback pain for many adults.http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01155.html

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Pharmaceutical researcher considering supply chains | Image credit: Freepik
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Mike Schaefers Simtra BioPharma Solutions, Shiva Khalafpour MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany
Chris Hagen, SCIEX
Daniel Fischer, Tevard
Junevity Co-founder & CEO, John Hoekman, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.